强直性脊柱炎患者外周血中调节性B细胞亚型的表达及其与疾病活动度的关系
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81160056)。


Frequencies of human regulatory B cells in PBMC in ankylosing spondylitis patients and its clinical significance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的:探讨强直性脊柱炎(ankylosing spondylitis,AS)中调节性B细胞(regulatory B cells,Breg)的水平及与疾病活动度间的关系。 方法:选取确诊AS患者38例,按BASDAI评分分为活动期21例和非活动期17例,同时选取30例健康人对照者,AS患者与对照组间一般资料差异无统计学意义。ASDAS-CRP和BASDAI评分作为疾病活动度评价指标。用流式细胞术检测AS患者外周血CD19+CD24hiCD38hiBreg、CD19+CD24hiCD27+Breg、CD4+CD25highTreg及CD3+IL-17+CD8-TH17比例,荧光定量PCR检测RORγt和Foxp3 mRNA表达水平。 结果: AS患者CD19+CD24hiCD38hiBreg比例为(2.10±0.16)%,显著低于对照组(3.44±0.80)%,其中活动期患者[(1.88±0.66)%]低于非活动期患者[(2.36±0.57)%],均低于对照组,差异均有统计学意义。AS患者CD19+CD24hiCD38hiBreg与Foxp3 mRNA成显著正相关性(r=0.369,P<0.05),与TH17、RORγt mRNA、BASDAI评分及ASDAS-CRP负相关(r分别为-0.338、-0.661、-0.411、-0.714,P均<0.05),而与Treg无相关性(r=-0.006,P>0.05)。而AS患者中CD19+CD24hiCD27+ Breg亚群比例与对照组间差异则无统计学意义,但活动期患者比例有所降低,与非活动期患者及对照组比较,差异有统计学意义。AS患者中CD19+CD24hiCD27hiBreg亚群比例与Foxp3 mRNA正相关(r=0.344,P<0.05),与ASDAS-CRP负相关(r=-0.383,P<0.05),但与TH17、Treg、RORγt mRNA及BASDAI评分均无显著相关性。 结论:AS患者中存在异常的Breg表型主要为CD19+CD24hiCD38hiBreg,其在AS患者中显著降低,并与疾病活动度密切相关,且与RORγt 和Foxp3 mRNA水平及TH17数量存在一定的关联。

    Abstract:

    Abstract: Objective:To determine the frequencies of regulatory B cells(Breg) in peripheral blood mononuclear cell(PBMC) in ankylosing spondylitis(AS) patients and its clinical association with AS. Methods:Thirty-eight consecutive patients with AS were included in this study. Based on BASDAI scores, AS patients were divided into active group(n=21) and inactive group(n=17). Thirty age- and sex-matched healthy individuals served as controls. ASDAS-CRP and BASDAI were used as indicators of AS disease activity. Flow cytometry was used to determine the frequencies of CD19+CD24hiCD38hiBreg, CD19+CD24hiCD27+Breg, CD4+CD25highTreg and CD3+IL-17+CD8-TH17 cells in the AS patients, and mRNA levels of RORγt and FoxP3 were examined by quantitative real-time PCR. The patients′ perceived disease activity was recorded by BASDAI and ASDAS using serum CRP levels(ASDAS CRP). Results: The percentage of CD19+CD24hiCD38hiBreg in AS patients [(2.10±0.16%)] was lower than that in healthy control [(2.10±0.16)% vs(3.44±0.80)%]. Among AS patients, higher proportion of CD19+CD24hiCD38hiBreg was observed in active patients compared with inactive patients [(1.88±0.66)% vs(2.36±0.57)%]. CD19+CD24hiCD38hiBreg ratio was significantly and positively correlated with the levels of Foxp3 mRNA(rFoxp3 mRNA<.sub>=0.369,P<0.05), and negatively related to TH17, RORγt mRNA, BASDAI and ASDAS-CRP socre(rTH17=-0.338, P<0.05; rRORγt mRNA=-0.661, P<0.01; rBASDAI=-0.411, P<0.05; rASDAS-CRP=-0.714, P<0.01), while they were slightly correlated with Treg(rTreg=-0.006, P>0.05). However, the frequency of CD19+CD24hiCD27+Breg, another type of defined Breg, did not show significantly different between AS patients and control. but the propotion of CD19+CD24hiCD27+Breg in active AS patients was lower than that in control or inactive cases, and the differences were statistically significant. In AS group, the frequency of CD19+CD24hiCD27+Breg was positively correlated with Foxp3 mRNA(rFoxp3 mRNA=0.344, P<0.05), and negatively correlated to ASDAS CRP(rASDAS-CRP=-0.383, P<0.05). No significant correlations were observed between the level of CD19+CD24hiCD27+Breg and TH17, Treg, RORγt mRNA and BASDAI. Conclusion: Our current study revealed that CD19+CD24hiCD38hiBreg was the typical abnormal Breg in AS patients. It was significantly decreased in PBMC of AS patients, and correlated with disease activity, suggesting that Breg may play an important role in the pathogenesis of AS. The results of correlation analysis indicated Breg was associated with RORγt mRNA,FoxP3 mRNA and the proportion of TH17 cells in AS.

    参考文献
    相似文献
    引证文献
引用本文

薛国辉,华琳,刘晓峰,陈雪礼,董亮,潘京,周南进.强直性脊柱炎患者外周血中调节性B细胞亚型的表达及其与疾病活动度的关系[J].临床检验杂志,2015,(9):662-667

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2015-07-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2016-01-21
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司